Daily equity-report  by epic research 4 jan 2013
Upcoming SlideShare
Loading in...5
×
 

Daily equity-report by epic research 4 jan 2013

on

  • 277 views

Epic Research is a leading financial services provider with presence in Indian and other global capital markets. Provides Stock Tips, Forex Tips, Commodity Tips, MCX Tips, Equity Tips, Tips, Intraday ...

Epic Research is a leading financial services provider with presence in Indian and other global capital markets. Provides Stock Tips, Forex Tips, Commodity Tips, MCX Tips, Equity Tips, Tips, Intraday Tips, NSE Tips, BSE Tips, COMEX Tips, PCG Pack and NCDEX Tips. We provide services in equity, commodity and Forex market.

Statistics

Views

Total Views
277
Views on SlideShare
277
Embed Views
0

Actions

Likes
0
Downloads
0
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

Daily equity-report  by epic research 4 jan 2013 Daily equity-report by epic research 4 jan 2013 Document Transcript

  • HEADLINES -=6  Indian Market Indian equity markets up by 0.27% Nifty up by 16.25 pts and settle at 6009.50 Sensex up by 50.54 pts at 19764.78 Bank Nifty down by 8.65 pts at 12778.20  Global Market DAILY EQUITY European markets were up with FTSE NEWSLETTER down by 9.43 closed at 6017,CAC down by 20.18 closed at 3713 and DAX down 4TH JANUARY 2013 by 25.01 closed at 7753. Dow future was down 20.00 closed at 13311.00  HEADLINES• Offtake target bigger challenge than production: Coal India• Govt may consider ordinance for Hindustan Zinc stake sale• IGL keen to buy ADB stake in Petronet LNG• Dr Reddys Laboratories launches hair loss tablets in US WWW.EPICRESEARCH.CO 09752199966
  •  MARKET ANALYSIS:  The 50-unit S&P CNX Nifty moved past the psychological 6,000 level as key benchmark indices eked out small gains. The barometer index, BSE Sensex, was provisionally up 38.66 points or 0.2%, up 59.61 points from the days low and off 33.40 points from the days high. The market breadth, indicating the overall health of the market, was positive. Index heavyweight Reliance Industries (RIL) extended intraday gains in late trade.  The BSE Sensex was up 38.66 points or 0.2% to 19,752.90.  The S&P CNX Nifty was up 12.15 points or 0.2% to 6,005.40.  Among the 30-share Sensex pack, 17 declined while the rest of them gained.  IT pivotals rose after US lawmakers early this week reached a last-minute deal to avert the fiscal cliff. US is the biggest outsourcing market for the Indian IT firmsIT major Tata Consultancy Services rose 1.5%.Indias third largest software services exporter by revenues Wipro gained 0.83%.Shares of banking giant State Bank of India (SBI) gained 0.88% to Rs 2,469.75 after striking a 52-week high of Rs 2,482.20 in intraday today, 3 January 2013. Dr Reddys Laboratories advanced 2.35% after the company said it has launched Finasteride Tablets 1 mg in the US market. STOCKS TO WATCH  FII’s and DII’s  CROMPTONCATEGORY DATE BUY SELL NET  ADANI FII 3-Jan-13 3089.48 1692.11 1397.37  BHEL  PFC DII 3-Jan-13 996.46 1902.42 -905.96 SCRIPS IN BAN PERIOD  NIFTY DAILY PIVOTS  SUZLONPIVOT R4 R3 R2 R1 PP S1 S2 S3 S4NIFTY 6097 6066 6035 6022 6004 5991 5973 5942 5911 WWW.EPICRESEARCH.CO 09752199966
  • .  GAINERS AND LOOSERS EXPERT OPINION NIFTY DAILY NIFTY GAINERS  Nifty looks ConsolidateSCRIPS RATE VOL. PR. NET %  Strategy: Buy on dips (000) CLOSE CHAN CHANG GE E  Support: 5970 Dr  Resistance: 6060Reddys 1882.30 584.79 1837.70 44.60 2.43 Lab BANK NIFTY Cairn 327.50 2442.67 320.00 7.50 2.34  Bank Nifty looks Consolidate India Bharti  Strategy: Buy on dips 328.00 3677.59 321.05 6.95 2.16 Airtel  Support: 12700 ONGC 279.80 4215.38 274.60 5.20 1.89  Resistance: 12840  .0 DLF 238.90 5511.61 235.20 3.70 1.57 PREVIOUS PERFORMANCE TYPE SCRIP B/S RESULT DAILY NIFTY LOOSERS NOT CASH AMTEK S EXECUTEDSCRIPS RATE VOL. PR. NET % ZEE TGT (000) CLOSE CHAN CHAN CASH B ENTERTAINMENT ACHEIVED GE GE ADANI NOT FUTURE B Tata ENTERPRISE EXECUTED 110.15 1607.01 112.00 -1.85 -1.65 Power HCL NOT FUTURE S TECHNOLOGIES EXECUTED Lupin 608.85 475.31 614.90 -6.05 -0.98 PNB 896.80 587.50 905.50 -8.70 -0.96 Sun Pharma 733.85 520.44 740.90 -7.05 -0.95 Inds. Hero 1887.95 334.61 1905.35 -17.40 -0.91MotoCorp 09752199966
  • MARKET CALLS CASH SCRIPS ACTION LEVEL 1ST TARGET 2ND TARGET STOP LOSS BHARTI AIRTEL BUY 328.90 330.90 333.90 326.90 ICICI BANK SELL 1168.00 1158.00 1145.00 1178.00 FUTURE ST ND SCRIPS ACTION LEVEL 1 TARGET 2 TARGET STOP LOSS. ALLAHBAD BANK BUY 181.30 182.30 183.80 180.30 ADANI SELL 282.00 281.00 279.50 283.00 ENETERPRISES Disclaimer The information and views in this report, our website & all the service we provide are believed to be reliable, but we do not accept any responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most. Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable. This material is for personal information and based upon it & takes no responsibility The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. Epic research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. Epic research shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of NSE and BSE. The share price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. Analyst or any person related to epic research might be holding positions in the stocks recommended. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for . Any surfing and reading of the information is the acceptance of this disclaimer. All Rights Reserved. Investment in equity & bullion market has its own risks. We, however, do not vouch for the accuracy or the completeness thereof. we are not responsible for any loss incurred whatsoever for any financial profits or loss which may arise from the recommendations above epic research does not purport to be an invitation or an offer to buy or sell any financial instrument. Our Clients (Paid Or Unpaid), Any third party or anyone else have no rights to forward or share our calls or SMS or Report or Any Information Provided by us to/with anyone which is received directly or indirectly by them. If found so then Serious Legal Actions can be taken.